EUVIMEDEUVIMED entdecken
Crossref

Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study

Jaume Aguado iD, Lia Gutierrez iD, Joan Forns iD, Julia Vila-Guilera iD, Kenneth J Rothman iD, Xabier García-Albéniz iD

American Journal of Epidemiology · 04.03.2025 · 194 (3) · 691-698

DOI: 10.1093/aje/kwae263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Epidemiology, online erschienen am 06.08.2024. Verfasst von Jaume Aguado und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain. Hauptthemen laut MEDLINE: Antihypertensive Agents, Cholinergic Antagonists, Alzheimer Disease, Dementia, Vascular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Professional Development Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studying the effect of duration of treatment on prognostic outcomes using real-world data is challenging because only people who survive for a long time can receive a treatment for a long time. Specifying a target trial helps overcome such challenge. We aimed to estimate the effect of different durations of treatment with antihypertensive drugs with anticholinergic properties (AC AHT) on the risk of vascular dementia and Alzheimer’s disease by emulating a target trial using the UK CPRD GOLD database (2001-2017). Comparing treatment for 3-6 years vs ≤3 years yielded null results for both types of dementia. Comparing a longer duration of treatment, >6 years vs ≤3 years, yielded a 10-year risk ratio of 0.69 (95% CI, 0.54-0.90) for vascular dementia and 0.91 (95% CI, 0.77-1.10) for Alzheimer’s disease. For illustration, we performed an analysis that failed to emulate a target trial by assigning exposure categories using postbaseline information, obtaining implausible beneficial estimates. Our findings indicate a modest benefit of longer duration of treatment with AC AHT on vascular dementia and highlight the value of the target trial emulation to avoid selection bias in the evaluation of the effect of different durations of treatment. This article is part of a Special Collection on Pharmacoepidemiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsCholinergic AntagonistsAlzheimer DiseaseDementia, VascularHypertensionDementiaDuration of TherapyHumansAgedFemaleMaleAged, 80 and overUnited KingdomTime FactorsRisk FactorsMiddle Aged

Stichwörter der Autor:innen

Alzheimer’s diseaseantihypertensivestarget trial emulationvascular dementia

Substanzen

Antihypertensive AgentsCholinergic Antagonists

Autor:innen und Institutionen

  • Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.
  • Pharmacoepidemiology and Risk Management, RTI Health Solutions, Waltham, MA, United States.

ORCID-Profile: Jaume Aguado, Lia Gutierrez, Joan Forns, Julia Vila-Guilera, Kenneth J Rothman, Xabier García-Albéniz

Förderung

  • Professional Development Award

Zitieren

APA

Aguado, J., Gutierrez, L., Forns, J., Vila-Guilera, J., Rothman, K. J., & García-Albéniz, X. (2025). Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study. American Journal of Epidemiology, 194(3), 691-698. https://doi.org/10.1093/aje/kwae263

Vancouver

Aguado J, Gutierrez L, Forns J, Vila-Guilera J, Rothman KJ, García-Albéniz X. Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study. American Journal of Epidemiology. 2025;194(3):691-698. doi:10.1093/aje/kwae263

BibTeX
@article{Aguado2025,
  author = {Aguado, Jaume and Gutierrez, Lia and Forns, Joan and Vila-Guilera, Julia and Rothman, Kenneth J and García-Albéniz, Xabier},
  title = {Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study},
  journal = {American Journal of Epidemiology},
  year = {2025},
  volume = {194},
  number = {3},
  pages = {691--698},
  doi = {10.1093/aje/kwae263}
}
Kostenlos starten →